Role of Pramipexole in Delaying L-dopa Induced Dyskinesia and Enhancing the Response to L-dopa in 1-methyl-4-phenyl 1,2,3,6-tetrahydropyridine-parkinsonian Mice
L-dopa remains the most effective treatment for Parkinson‟s disease (PD). However, its effectiveness declines on continuous use, leads to motor complications, and does not modify the progression of the neurodegenerative process. Medical therapy that provides the benefits of l-dopa without motor comp...
Main Author: | Mona K. Tawfik |
---|---|
Format: | Article |
Language: | English |
Published: |
KenzPub
2012-06-01
|
Series: | Egyptian Journal of Basic and Clinical Pharmacology |
Online Access: | http://www.kenzpub.com/journals/ejbcp/2012/101332/ |
Similar Items
-
Propranolol Relieves L-Dopa-Induced Dyskinesia in Parkinsonian Mice
by: Ziqing Shi, et al.
Published: (2020-11-01) -
Spontaneous locomotor activity and L-DOPA-induced dyskinesia are not linked in 6-OHDA parkinsonian rats
by: Stefania eSgroi, et al.
Published: (2014-10-01) -
The locus coeruleus is directly implicated in L-DOPA-induced dyskinesia in parkinsonian rats: an electrophysiological and behavioural study.
by: Cristina Miguelez, et al.
Published: (2011-01-01) -
Effect of a selective glutamate antagonist on l-dopa-induced dyskinesias in drug-naive parkinsonian monkeys
by: Abdallah Hadj Tahar, et al.
Published: (2004-03-01) -
Studies on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and analogs
by: Bucy, Teresa B.
Published: (2014)